Healthcare -
Biotechnology - NASDAQ - US
$ 5.76
-2.21 %
$ 465 M
Market Cap
-2.85
P/E
KURA - CASH & EQUIVALENTS
Cash & Equivalents KURA - Kura Oncology, Inc.
224 M
LAST VALUE
108.16%
2 YEAR CAGR
53.74%
5 YEAR CAGR
69.84%
10 YEAR CAGR